InsiderSignal.AI

InsiderSignal.ai

VIR - Vir Biotechnology, Inc.

Insider Sale by Sato Vicki L (Dir)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

4 days ago, Sato Vicki L, serving as Dir at Vir Biotechnology, Inc. (VIR), sold 22,000 shares at $9.07 per share, for a total transaction value of $199,617.00. Following this transaction, Sato Vicki L now holds 1,100,391 shares of VIR.

This sale represents a 2.00% decrease in Sato Vicki L's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, April 1, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, April 2, 2026, 1 day after the trade was made.

Vir Biotechnology, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Sato Vicki L

Dir

Vicki L. Sato, Ph.D. is an accomplished biotech executive serving as Chairman of the Board of Directors at Vir Biotechnology, Inc. (VIR) since December 2016.[[1]](https://www.vir.bio/team/vicky-sato/)[[7]](https://www.marketscreener.com/insider/VICKI-SATO-A02O37/) She is currently a venture partner at ARCH Venture Partners and serves on the board of Allogene Therapeutics, Inc., while having been a member of President Biden’s Council of Advisors on Science and Technology (PCAST) from 2021 to 2025.[[1]](https://www.vir.bio/team/vicky-sato/)[[2]](https://en.wikipedia.org/wiki/Vicki_Sato) Dr. Sato's career highlights include her tenure as President of Vertex Pharmaceuticals from 2000 to 2005, after roles as Chief Scientific Officer and Senior VP of R&D, contributing to drugs like Avonex, Tysabri, and Telaprevir; earlier, she was VP of Research at Biogen, Inc.[[1]](https://www.vir.bio/team/vicky-sato/)[[2]](https://en.wikipedia.org/wiki/Vicki_Sato)[[5]](https://www.youtube.com/watch?v=zeQBQ2KOaVM) A retired professor of management practice at Harvard Business School and professor in molecular and cell biology at Harvard University, she holds an A.B. in Biology from Radcliffe College, and A.M. and Ph.D. in Biology from Harvard.[[1]](https://www.vir.bio/team/vicky-sato/)[[2]](https://en.wikipedia.org/wiki/Vicki_Sato) Recently, as VIR Director, she sold shares totaling $169,670 on February 2, 2026, and exercised/sold additional shares under a Rule 10b5-1 plan.[[3]](https://www.investing.com/news/insider-trading-news/vir-biotechnology-director-sato-sells-169k-in-stock-93CH-4482602)[[6]](https://www.stocktitan.net/sec-filings/VIR/form-4-vir-biotechnology-inc-insider-trading-activity-67d8958a0bb1.html)

View full insider profile →

Trade Price

$9.07

Quantity

22,000

Total Value

$199,617.00

Shares Owned

1,100,391

Trade Date

Wednesday, April 1, 2026

4 days ago

SEC Filing Date

Thursday, April 2, 2026

Filed 1 day after trade

HEALTHCAREBIOTECHNOLOGY

About Vir Biotechnology, Inc.

Company Overview

No company information available
View news mentioning VIR

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5305051

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime